Logo image of ERNA

ERNEXA THERAPEUTICS INC (ERNA) Stock Price, Quote, News and Overview

NASDAQ:ERNA - Nasdaq - US1140822099 - Common Stock - Currency: USD

1.92  -0.04 (-2.04%)

After market: 1.8805 -0.04 (-2.06%)

ERNA Quote, Performance and Key Statistics

ERNEXA THERAPEUTICS INC

NASDAQ:ERNA (7/15/2025, 8:00:01 PM)

After market: 1.8805 -0.04 (-2.06%)

1.92

-0.04 (-2.04%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High34.35
52 Week Low1.75
Market Cap14.13M
Shares7.36M
Float2.88M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-11 2025-08-11
IPO08-29 1991-08-29


ERNA short term performance overview.The bars show the price performance of ERNA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

ERNA long term performance overview.The bars show the price performance of ERNA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ERNA is 1.92 USD. In the past month the price decreased by -16.16%. In the past year, price decreased by -94.05%.

ERNEXA THERAPEUTICS INC / ERNA Daily stock chart

ERNA Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.15 329.24B
AMGN AMGEN INC 14.09 157.29B
GILD GILEAD SCIENCES INC 14.09 135.66B
VRTX VERTEX PHARMACEUTICALS INC N/A 119.21B
REGN REGENERON PHARMACEUTICALS 12.37 59.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 40.57B
ARGX ARGENX SE - ADR 96.69 33.95B
ONC BEONE MEDICINES LTD-ADR 6.89 29.19B
BNTX BIONTECH SE-ADR N/A 26.60B
NTRA NATERA INC N/A 20.46B
INSM INSMED INC N/A 19.52B
BIIB BIOGEN INC 8.06 18.68B

About ERNA

Company Profile

ERNA logo image Ernexa Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 6 full-time employees. Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The firm is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The firm seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The firm is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.

Company Info

ERNEXA THERAPEUTICS INC

1035 Cambridge Street, Suite 18A

Cambridge MASSACHUSETTS US

Employees: 6

ERNA Company Website

ERNA Investor Relations

Phone: 16177986700

ERNEXA THERAPEUTICS INC / ERNA FAQ

What is the stock price of ERNEXA THERAPEUTICS INC today?

The current stock price of ERNA is 1.92 USD. The price decreased by -2.04% in the last trading session.


What is the ticker symbol for ERNEXA THERAPEUTICS INC stock?

The exchange symbol of ERNEXA THERAPEUTICS INC is ERNA and it is listed on the Nasdaq exchange.


On which exchange is ERNA stock listed?

ERNA stock is listed on the Nasdaq exchange.


What is ERNEXA THERAPEUTICS INC worth?

ERNEXA THERAPEUTICS INC (ERNA) has a market capitalization of 14.13M USD. This makes ERNA a Nano Cap stock.


How many employees does ERNEXA THERAPEUTICS INC have?

ERNEXA THERAPEUTICS INC (ERNA) currently has 6 employees.


What are the support and resistance levels for ERNEXA THERAPEUTICS INC (ERNA) stock?

ERNEXA THERAPEUTICS INC (ERNA) has a support level at 1.82 and a resistance level at 2.01. Check the full technical report for a detailed analysis of ERNA support and resistance levels.


Should I buy ERNEXA THERAPEUTICS INC (ERNA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ERNEXA THERAPEUTICS INC (ERNA) stock pay dividends?

ERNA does not pay a dividend.


When does ERNEXA THERAPEUTICS INC (ERNA) report earnings?

ERNEXA THERAPEUTICS INC (ERNA) will report earnings on 2025-08-11.


What is the Price/Earnings (PE) ratio of ERNEXA THERAPEUTICS INC (ERNA)?

ERNEXA THERAPEUTICS INC (ERNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-93.66).


ERNA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ERNA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ERNA. Both the profitability and financial health of ERNA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ERNA Financial Highlights

Over the last trailing twelve months ERNA reported a non-GAAP Earnings per Share(EPS) of -93.66. The EPS decreased by -46.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -911.44%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%87.51%
Sales Q2Q%-100%
EPS 1Y (TTM)-46.89%
Revenue 1Y (TTM)369.3%

ERNA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to ERNA. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners2.39%
Ins Owners9.45%
Short Float %N/A
Short Ratio0.17
Analysts
Analysts43.33
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A